ArticleRespirology case reports2024

Treatment with low-dose nintedanib and tacrolimus in patients with progressive fibrosing interstitial lung diseases with anti-ARS antibody-positive dermatomyositis.

Takeshi Kawaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.